Back to Search
Start Over
Studies from Kyorin University in the Area of Glioblastomas Described [Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker Study]
- Source :
- Immunotherapy Weekly. December 14, 2022, 1481
- Publication Year :
- 2022
-
Abstract
- 2022 DEC 14 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Research findings on glioblastomas are discussed in a new report. According to news originating from [...]
- Subjects :
- Immunotherapy -- Reports -- Research
Glioblastoma multiforme -- Research
Health
Subjects
Details
- Language :
- English
- ISSN :
- 10908625
- Database :
- Gale General OneFile
- Journal :
- Immunotherapy Weekly
- Publication Type :
- News
- Accession number :
- edsgcl.729665199